Supplementation of oral nutrition with pancreatic enzymes improves the nutritional status of aged endotoxemic rats.
Malnutrition is a common problem in elderly people. The association of malnutrition and physical illness or injury leads to both localized and general complications. In particular, impairment of the adaptive response of pancreatic function to undernutrition and refeeding may adversely affect nutritional status and elicit morbidity and mortality. Aged rats (24 mo old) were treated with lipopolysaccharide (LPS) from E. Coli (3 mg/kg body weight). Six days later, survivors were randomized to receive, for 7 days, an oral chow diet enriched with either a pancreatic extract (PE) (2.4 mg/day) or an isonitrogenous supply of casein (CAS). Endotoxemia induced a catabolic state, with a body weight loss of 7.6 +/- 1.1% on day two after LPS treatment. Mean food intake from day 6 to day 13 was similar in LPS-PE and LPS-CAS groups (19.0 +/- 5.6 versus 19.7 +/- 6.9 g). The metabolic response varied according to the type of muscle studied. In fast (white) muscle, the protein content and the glutamine pool remained markedly depleted in endotoxemic rats receiving casein supplementation. In contrast, enrichment of nutrition with PE significantly limited the LPS-induced muscle wasting and increased the muscle glutamine content. As in previous observations, no significant change occurred in slow (red) muscle. These results could indicate that PE supplementation counteracts pancreatic deficiency caused by aging and worsened by stress and this, in turn, could improve the efficiency of nutrition, to support the hypermetabolism of aged injured rats.
Farges
M C
MC
Biochemistry Molecular Biology and Nutrition Laboratory, Pharmacy School and Research Center of Human Nutrition, Clermont-Ferrand, France.
Vasson
M P
MP
Davot
P
P
Villie
F
F
Meunier
M T
MT
Marcollet
M
M
Cynober
L
L
D000375:Aging; D000596:Amino Acids / Q000032:analysis; D000818:Animals; D001835:Body Weight; D004032:Diet; D004435:Eating; D019446:Endotoxemia / Q000628:therapy*; D057487:Enzyme Therapy; D004798:Enzymes / Q000008:administration & dosage; D004926:Escherichia coli; D008070:Lipopolysaccharides; D008297:Male; D009124:Muscle Proteins / Q000032:analysis; D009132:Muscles / Q000033:anatomy & histology / Q000737:chemistry; D009752:Nutritional Status; D009929:Organ Size; D010179:Pancreas / Q000201:enzymology*; D051381:Rats; D017207:Rats, Sprague-Dawley
D000596:Amino Acids; D004798:Enzymes; D008070:Lipopolysaccharides; D009124:Muscle Proteins